Literature DB >> 22133447

Opioid-free single-incision laparoscopic (SIL) cholecystectomy using bilateral TAP blocks.

Kai Matthes1, Mark A Gromski, Benjamin E Schneider, Joan E Spiegel.   

Abstract

A 30 year old woman who was 8 weeks postpartum with a history of cholelithiasis and gallstone pancreatitis, and who was status-post endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy, was treated with a single-incision laparoscopic (SIL) cholecystectomy. A transversus abdominis plane block (TAP) was performed after induction of anesthesia. The patient required no intraoperative or postoperative opioids.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22133447     DOI: 10.1016/j.jclinane.2011.04.014

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

Review 1.  American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.

Authors:  Christopher L Wu; Adam B King; Timothy M Geiger; Michael C Grant; Michael P W Grocott; Ruchir Gupta; Jennifer M Hah; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Michael G Mythen; Matthew D McEvoy
Journal:  Anesth Analg       Date:  2019-08       Impact factor: 5.108

2.  Analgesic efficacy of ultrasound guided transversus abdominis plane block versus local anesthetic infiltration in adult patients undergoing single incision laparoscopic cholecystectomy: A randomized controlled trial.

Authors:  Ejas P Bava; Rashmi Ramachandran; Vimi Rewari; Virinder Kumar Bansal; Anjan Trikha
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec

3.  The efficacy of transversus abdominis plane block for postoperative analgesia in laparoscopic cholecystectomy cases: a retrospective evaluation of 515 patients.

Authors:  Arzu Esen Tekeli; Esra Eker; Mehmet Kadir Bartin; Muzaffer Önder Öner
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.